GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chugai Pharmaceutical Co Ltd (OTCPK:CHGCF) » Definitions » 5-Year Yield-on-Cost %

Chugai Pharmaceutical Co (Chugai Pharmaceutical Co) 5-Year Yield-on-Cost % : 5.53 (As of Apr. 27, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Chugai Pharmaceutical Co 5-Year Yield-on-Cost %?

Chugai Pharmaceutical Co's yield on cost for the quarter that ended in Mar. 2024 was 5.53.


The historical rank and industry rank for Chugai Pharmaceutical Co's 5-Year Yield-on-Cost % or its related term are showing as below:

CHGCF' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.83   Med: 4.73   Max: 8.36
Current: 5.53


During the past 13 years, Chugai Pharmaceutical Co's highest Yield on Cost was 8.36. The lowest was 1.83. And the median was 4.73.


CHGCF's 5-Year Yield-on-Cost % is ranked better than
81.16% of 499 companies
in the Drug Manufacturers industry
Industry Median: 2.22 vs CHGCF: 5.53

Competitive Comparison of Chugai Pharmaceutical Co's 5-Year Yield-on-Cost %

For the Drug Manufacturers - General subindustry, Chugai Pharmaceutical Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chugai Pharmaceutical Co's 5-Year Yield-on-Cost % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Chugai Pharmaceutical Co's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Chugai Pharmaceutical Co's 5-Year Yield-on-Cost % falls into.



Chugai Pharmaceutical Co 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Chugai Pharmaceutical Co is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Chugai Pharmaceutical Co  (OTCPK:CHGCF) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Chugai Pharmaceutical Co 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Chugai Pharmaceutical Co's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Chugai Pharmaceutical Co (Chugai Pharmaceutical Co) Business Description

Traded in Other Exchanges
Address
1-1 Nihonbashi-Muromachi 2-Chome, Nihonbashi Mitsui Tower (Reception15F), Chuo-ku, Tokyo, JPN, 103-8324
Chugai Pharmaceutical is a Japanese drug developer and subsidiary of Roche Holding Ltd, which owns roughly 60% of the company. Founded in 1925, Chugai deals primarily in the Japanese market, where it generates roughly half of its revenue. It has been the leader in Japan's oncology market for the past decade, largely due to drugs licensed from its parent's portfolio. The company also develops its own innovative medicines. It is an industry leader in antibody technology with several flagship therapies, including Hemlibra for hemophilia A patients and tocilizumab for treating rheumatoid arthritis and COVID-19.

Chugai Pharmaceutical Co (Chugai Pharmaceutical Co) Headlines